ArticleBlood research2017

Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial.

Jeongkuk Seo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.